Trials in Progress: Phase 1a/b Study of ELVN-002, in Solid Tumors with HER2 Mutations, Amplification or Overexpression
JOURNAL OF THORACIC ONCOLOGY（2023）
Key words
HER2 mutant non-small cell lung cancer,Phase 1 study,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined